DrugPatentWatch Database Preview
Cipla Company Profile
What is the competitive landscape for CIPLA, and what generic and branded alternatives to CIPLA drugs are available?
CIPLA has seventy-two approved drugs.
There are thirty-two tentative approvals on CIPLA drugs.
Summary for Cipla
| US Patents: | 0 |
| Tradenames: | 64 |
| Ingredients: | 64 |
| NDAs: | 72 |
| Patent Litigation for Cipla: | See patent lawsuits for Cipla |
| PTAB Cases with Cipla as petitioner: | See PTAB cases with Cipla as petitioner |
Drugs and US Patents for Cipla
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipla Ltd | ZALEPLON | zaleplon | CAPSULE;ORAL | 077505-001 | Jun 20, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Cipla Ltd | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065361-001 | Oct 22, 2007 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Cipla Ltd | EMTRICITABINE | emtricitabine | CAPSULE;ORAL | 091168-001 | Jul 2, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Cipla Ltd | CARBOPLATIN | carboplatin | INJECTABLE;INJECTION | 077383-002 | Jan 27, 2006 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
